Current Issue

Cancer Treatment Reviews

December 2021Volume 101

Current Issue Links

• Articles in Press
• Past Issues

Submit Mobile

• Submit article

Explore

• Subscribe
• Reprints
• Career Opportunities

Publish

• Submit Article
   
• Aims and Scope
• For Authors
• Supports Open Access
   

Connect

• Alerts
• Twitter
   

Articles in Press

• 
  Review article

  Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2- breast cancer: Available Evidence and Clinical Implications

  Griguolo et al.

  Published online: December 2, 2021
• 
  Review article

  Open Access

  Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities

  Bauer et al.

  Published online: November 30, 2021

View All

Issue Highlights

• 

  Review article

  Targeting HER2 heterogeneity in breast cancer

  Hamilton et al.

  Published online: September 1, 2021
• Review article

  Systemic therapy for older patients with early breast cancer

  Battisti et al.

  Published online: September 10, 2021
• 

  Review articleOpen Access

  Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000–19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4

  Bray et al.

  Published online: September 9, 2021
• 

  Review articleOpen Access

  The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas

  You et al.

  Published online: September 14, 2021

About

Cancer Treatment Reviews

(Incorporating Evidence-based Oncology) is an international review journal that will keep both the clinician and researcher abreast of modern concepts and developments in cancer treatment research through the publication of state of the art, authoritative reviews; evidence-based reviews (using a priori defined selection process to identify key articles from the literature and reviewing them in the form of a structured abstract, evidence summary and commentary); and systematic reviews.

Metrics

Metrics

##

Impact Factor

##

5-Year Impact Factor

• More Journal Metrics
   
• Submit a Manuscript
   
• Top Social Media Articles
   
• Time to Online Publication
   

COVID-19

• 

  Complications of TreatmentOpen Access

  SARS-CoV-2 and cancer: Are they really partners in crime?

  van Dam et al.

  Published online: July 10, 2020
• Anti-tumour Treatment

  Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics

  Fares et al.

  Published online: June 29, 2020
• Hot Topic

  Free

  Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

  Fontana et al.

  Published online: June 10, 2020
• Hot Topic

  Free

  Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)

  Slimano et al.

  Published online: June 22, 2020
• 

  Hot Topic

  Free

  Cancer and COVID-19: Unmasking their ties

  Addeo et al.

  Published online: June 3, 2020
• 

  Systematic or Meta-analysis Studies

  Free

  The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer

  Surujballi et al.

  Published online: March 23, 2021

Most Read (Last 30 Days)

• 
  Anti-tumour Treatment

  Open Access

  Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

  Garcia et al.

  Published online: March 26, 2020
• 
  Review article

  Open Access

  KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond

  Nagasaka et al.

  Published online: October 20, 2021
• 
  Anti-tumour Treatment

  Open Access

  Immunotherapy in non-small cell lung cancer harbouring driver mutations

  Addeo et al.

  Published online: March 18, 2021
• 
  Anti-tumour Treatment

  Open Access

  Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge

  Jackisch et al.

  Published online: May 19, 2021
• 
  Anti-tumour Treatment

  Open Access

  Microsatellite instability in Gastric Cancer: Between lights and shadows

  Puliga et al.

  Published online: March 1, 2021
• 
  Anti-tumour Treatment

  Open Access

  MYC as a target for cancer treatment

  Duffy et al.

  Published online: January 18, 2021

Most Cited (Previous 3 Years)

• Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors

  • Krishnamurthy et al.

  Cancer Treatment Reviews, Vol.62, p50-60

  January 2018

• CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

  • Tokunaga et al.

  Cancer Treatment Reviews, Vol.63, p40-47

  February 2018

• Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies

  • Lee et al.

  Cancer Treatment Reviews, Vol.62, p110-122

  January 2018

• Targeting the microenvironment in solid tumors

  • Belli et al.

  Cancer Treatment Reviews, Vol.65, p22-32

  April 2018
• Open Access

  Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

  • Garcia et al.

  Cancer Treatment Reviews, Vol.86, 102017

  June 2020

Tweets by OncologyAdvance